Skip to main content

Peer Review reports

From: Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

Original Submission
2 Nov 2015 Submitted Original manuscript
26 Nov 2015 Reviewed Reviewer Report - Ana-Maria Florea
1 Dec 2015 Reviewed Reviewer Report - Gregory Calip
21 Dec 2015 Author responded Author comments - Lisenko Katharina
Resubmission - Version 2
21 Dec 2015 Submitted Manuscript version 2
2 Jan 2016 Reviewed Reviewer Report - Gregory Calip
4 Jan 2016 Reviewed Reviewer Report - Ana-Maria Florea
3 Feb 2016 Author responded Author comments - Lisenko Katharina
Resubmission - Version 3
3 Feb 2016 Submitted Manuscript version 3
18 Feb 2016 Author responded Author comments - Lisenko Katharina
Resubmission - Version 4
18 Feb 2016 Submitted Manuscript version 4
29 Feb 2016 Author responded Author comments - Lisenko Katharina
Resubmission - Version 5
29 Feb 2016 Submitted Manuscript version 5
Publishing
22 Mar 2016 Editorially accepted
11 Apr 2016 Article published 10.1186/s12885-016-2289-y

You can find further information about peer review here.

Back to article page